BGT-1 Antibodies

Santa Cruz Biotechnology offers a broad range of BGT-1 monoclonal antibodies for research focused on understanding BGT-1 protein function. BGT-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BGT-1, or Brain Glucose Transporter 1, is crucial for the transport of glucose across the blood-brain barrier, playing a significant role in maintaining glucose homeostasis in the brain. BGT-1 function is vital for neuronal health and energy metabolism, making it an important target for research in neurodegenerative diseases and metabolic disorders. Understanding BGT-1 mechanisms can provide insights into therapeutic strategies for conditions such as Alzheimer's disease and diabetes. Researchers worldwide utilize BGT-1 monoclonal antibodies to investigate glucose transport pathways and their impact on cellular function. Advanced research techniques supported by BGT-1 monoclonal antibodies enable detailed examination of protein expression, localization, and interactions. Santa Cruz Biotechnology monoclonal antibodies for BGT-1 support researchers in advancing scientific understanding of glucose transport mechanisms and their role in neurological health.